122 related articles for article (PubMed ID: 7585635)
1. Genetic radiotherapy overcomes tumor resistance to cytotoxic agents.
Seung LP; Mauceri HJ; Beckett MA; Hallahan DE; Hellman S; Weichselbaum RR
Cancer Res; 1995 Dec; 55(23):5561-5. PubMed ID: 7585635
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
Staba MJ; Mauceri HJ; Kufe DW; Hallahan DE; Weichselbaum RR
Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548
[TBL] [Abstract][Full Text] [Related]
3. Increased injection number enhances adenoviral genetic radiotherapy.
Mauceri HJ; Seung LP; Grdina WL; Swedberg KA; Weichselbaum RR
Radiat Oncol Investig; 1997; 5(5):220-6. PubMed ID: 9372544
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.
Mauceri HJ; Hanna NN; Wayne JD; Hallahan DE; Hellman S; Weichselbaum RR
Cancer Res; 1996 Oct; 56(19):4311-4. PubMed ID: 8813113
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells.
Weichselbaum RR; Hallahan DE; Beckett MA; Mauceri HJ; Lee H; Sukhatme VP; Kufe DW
Cancer Res; 1994 Aug; 54(16):4266-9. PubMed ID: 8044769
[TBL] [Abstract][Full Text] [Related]
6. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
Hanna NN; Mauceri HJ; Wayne JD; Hallahan DE; Kufe DW; Weichselbaum RR
Cancer Res; 1997 Oct; 57(19):4205-9. PubMed ID: 9331076
[TBL] [Abstract][Full Text] [Related]
7. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer.
Xiang J; Chen Y; Moyana T
Cancer Gene Ther; 2000 Jul; 7(7):1023-33. PubMed ID: 10917205
[TBL] [Abstract][Full Text] [Related]
8. Immunohistological analysis of immune cell infiltration of a human colon tumor xenograft after treatment with Stealth liposome-encapsulated tumor necrosis factor-alpha and radiation.
Kim DW; Andres ML; Miller GM; Cao JD; Green LM; Seynhaeve AL; Ten Hagen TL; Gridley DS
Int J Oncol; 2002 Nov; 21(5):973-9. PubMed ID: 12370743
[TBL] [Abstract][Full Text] [Related]
9. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy.
Urano M; Kuroda M; Reynolds R; Oberley TD; St Clair DK
Cancer Res; 1995 Jun; 55(12):2490-3. PubMed ID: 7780953
[TBL] [Abstract][Full Text] [Related]
10. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
11. Combination of pGL1-TNF-alpha gene and radiation (proton and gamma-ray) therapy against brain tumor.
Gridley DS; Li J; Kajioka EH; Andres ML; Moyers MF; Slater JM
Anticancer Res; 2000; 20(6B):4195-203. PubMed ID: 11205248
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancer.
Chung TD; Mauceri HJ; Hallahan DE; Yu JJ; Chung S; Grdina WL; Yajnik S; Kufe DW; Weichselbaum RR
Cancer Gene Ther; 1998; 5(6):344-9. PubMed ID: 9917088
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pGL1-TNF-alpha therapy in combination with radiation.
Li J; Andres ML; Fodor I; Nelson GA; Gridley DS
Oncol Res; 1998; 10(7):379-87. PubMed ID: 10063972
[TBL] [Abstract][Full Text] [Related]
14. Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy.
Ito A; Shinkai M; Honda H; Kobayashi T
Cancer Gene Ther; 2001 Sep; 8(9):649-54. PubMed ID: 11593333
[TBL] [Abstract][Full Text] [Related]
15. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha mediates the antitumor effect of combined interleukin-2 and whole body hyperthermia.
Fritz KL; Koziol S; Fabian DF; Lefor AT
J Surg Res; 1996 Jan; 60(1):55-60. PubMed ID: 8592432
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha augments radiation effects against human colon tumor xenografts.
Gridley DS; Hammond SN; Liwnicz BH
Anticancer Res; 1994; 14(3A):1107-12. PubMed ID: 8074459
[TBL] [Abstract][Full Text] [Related]
18. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter.
Luna MC; Ferrario A; Wong S; Fisher AM; Gomer CJ
Cancer Res; 2000 Mar; 60(6):1637-44. PubMed ID: 10749134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
